{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T08:38:30Z","timestamp":1782290310827,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08 NS096219"],"award-info":[{"award-number":["K08 NS096219"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ymgme.2021.08.009","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T02:01:42Z","timestamp":1629511302000},"page":"164-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Natural history of Tay-Sachs disease in sheep"],"prefix":"10.1016","volume":"134","author":[{"given":"Brett","family":"Story","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toloo","family":"Taghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jey","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Randle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayly","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Carl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siauna","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Fernau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Diffie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cuddon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Corado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundeep","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Sena-Esteves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Kolodny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuntian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Gray-Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2021.08.009_bb0005","series-title":"GeneReviews((R))","author":"Kaback","year":"1993"},{"key":"10.1016\/j.ymgme.2021.08.009_bb0010","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1542\/peds.2008-0635","article-title":"Lysosomal storage disorders in the newborn","volume":"123","author":"Staretz-Chacham","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2021.08.009_bb0015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.pediatrneurol.2010.02.007","article-title":"Infantile Sandhoff's disease with peripheral neuropathy","volume":"42","author":"Jain","year":"2010","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0020","doi-asserted-by":"crossref","first-page":"e1233","DOI":"10.1542\/peds.2011-0078","article-title":"Natural history of infantile G(M2) gangliosidosis","volume":"128","author":"Bley","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2021.08.009_bb0025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0003-2670(01)84537-2","article-title":"A bio-selective membrane electrode prepared with living bacterial cells","volume":"94","author":"Rechnitz","year":"1977","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ymgme.2021.08.009_bb0030","doi-asserted-by":"crossref","first-page":"e1550","DOI":"10.1542\/peds.2006-0588","article-title":"The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported","volume":"118","author":"Maegawa","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2021.08.009_bb0035","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000112174","article-title":"The clinical aspects of adult hexosaminidase deficiencies","volume":"13","author":"Federico","year":"1991","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0040","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/mus.21061","article-title":"Late-onset Tay-Sachs disease: the spectrum of peripheral neuropathy in 30 affected patients","volume":"38","author":"Shapiro","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2021.08.009_bb0045","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/jnnp.2009.177089","article-title":"New cases of adult-onset Sandhoff disease with a cerebellar or lower motor neuron phenotype","volume":"81","author":"Delnooz","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2021.08.009_bb0050","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/ana.410170413","article-title":"Motor neuron disease and adult hexosaminidase A deficiency in two families: evidence for multisystem degeneration","volume":"17","author":"Mitsumoto","year":"1985","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.expneurol.2017.09.012","article-title":"Murine sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease","volume":"299","author":"Seyrantepe","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0075","first-page":"27","article-title":"A review of gene therapy in canine and feline models of lysosomal storage disorders. Human gene therapy","volume":"26","author":"Bradbury","year":"2015","journal-title":"Clin. Develop."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0080","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/mt.2013.86","article-title":"Therapeutic response in feline sandhoff disease despite immunity to intracranial gene therapy","volume":"21","author":"Bradbury","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0085","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.expneurol.2014.09.020","article-title":"Biomarkers for disease progression and AAV therapeutic efficacy in feline Sandhoff disease","volume":"263","author":"Bradbury","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuroscience.2016.10.047","article-title":"AAV-mediated gene delivery attenuates neuroinflammation in feline Sandhoff disease","volume":"340","author":"Bradbury","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.ymgme.2021.08.009_bb0095","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ymgme.2015.05.003","article-title":"Mucopolysaccharidosis-like phenotype in feline Sandhoff disease and partial correction after AAV gene therapy","volume":"116","author":"Gray-Edwards","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2021.08.009_bb0100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/gt.2014.108","article-title":"Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of sandhoff disease","volume":"22","author":"McCurdy","year":"2015","journal-title":"Gene Ther"},{"key":"10.1016\/j.ymgme.2021.08.009_bb0105","doi-asserted-by":"crossref","DOI":"10.1177\/1759091415569908","article-title":"AAV-mediated gene delivery in a feline model of Sandhoff disease corrects lysosomal storage in the central nervous system","volume":"7","author":"Rockwell","year":"2015","journal-title":"ASN Neuro"},{"key":"10.1016\/j.ymgme.2021.08.009_bb0110","doi-asserted-by":"crossref","first-page":"10373","DOI":"10.1073\/pnas.0603765103","article-title":"Effective gene therapy in an authentic model of Tay-Sachs-related diseases","volume":"103","author":"Cachon-Gonzalez","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0115","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ymthe.2017.01.009","article-title":"Novel biomarkers of human GM1 gangliosidosis reflect the clinical efficacy of gene therapy in a feline model","volume":"25","author":"Gray-Edwards","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0120","series-title":"Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology, Masson's Trichrome Method","author":"Luna","year":"1968"},{"key":"10.1016\/j.ymgme.2021.08.009_bb0125","doi-asserted-by":"crossref","first-page":"35286","DOI":"10.1074\/jbc.M306126200","article-title":"Presence of an unusual GM2 derivative, taurine-conjugated GM2, in Tay-Sachs brain","volume":"278","author":"Li","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0130","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1523\/JNEUROSCI.2029-18.2019","article-title":"Heterogeneity of activity-induced sodium transients between astrocytes of the mouse hippocampus and neocortex: mechanisms and consequences","volume":"39","author":"Ziemens","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0135","first-page":"2037","article-title":"MR imaging and proton spectroscopy of neuronal injury in late-onset GM2 gangliosidosis","volume":"26","author":"Inglese","year":"2005","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00431-007-0469-0","article-title":"Serial 1H-MRS in GM2 gangliosidoses","volume":"167","author":"Assadi","year":"2008","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0145","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00247-005-1542-3","article-title":"Proton MR spectroscopy in three children with Tay-Sachs disease","volume":"35","author":"Aydin","year":"2005","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0150","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e318227b215","article-title":"Teaching NeuroImages: MRI in infantile Sandhoff disease","volume":"77","author":"Seshadri","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2021.08.009_bb0155","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/archneur.65.12.1669","article-title":"Thalamic changes in Tay-Sachs' disease","volume":"65","author":"Sharma","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0160","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1055\/s-0029-1202285","article-title":"Serial MR imaging and 1H-MR spectroscopy in monozygotic twins with Tay-Sachs disease","volume":"39","author":"Imamura","year":"2008","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ymgme.2021.08.009_bb0165","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4103\/1817-1745.92824","article-title":"Neuroradiological findings in GM2 gangliosidosis variant B1","volume":"6","author":"Bano","year":"2011","journal-title":"J. Pediatr. Neurosci."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0170","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13023-020-01354-3","article-title":"Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseases","volume":"15","author":"Lyn","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0175","doi-asserted-by":"crossref","first-page":"e705","DOI":"10.1212\/WNL.0000000000008959","article-title":"Quantitative oculomotor and nonmotor assessments in late-onset GM2 gangliosidosis","volume":"94","author":"Stephen","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2021.08.009_bb0180","first-page":"72","article-title":"The pathology of Tay-Sachs' disease","volume":"30","author":"Aronson","year":"1954","journal-title":"Bull. N. Y. Acad. Med."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0185","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1001\/archneur.1976.00500020048008","article-title":"Adult (chronic) GM2 gangliosidosis. Atypical spinocerebellar degeneration in a Jewish sibship","volume":"33","author":"Rapin","year":"1976","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0190","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.omtm.2017.07.005","article-title":"Lipidomic evaluation of feline neurologic disease after AAV gene therapy","volume":"6","author":"Gray-Edwards","year":"2017","journal-title":"Mol. Ther. Meth. Clin. Dev."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0195","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1177\/0300985810388522","article-title":"Pathology of GM2 gangliosidosis in Jacob sheep","volume":"48","author":"Porter","year":"2011","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0200","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00401-004-0848-9","article-title":"The leukoencephalopathy of infantile GM1 gangliosidosis: oligodendrocytic loss and axonal dysfunction","volume":"107","author":"van der Voorn","year":"2004","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0205","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.omtm.2019.11.023","article-title":"7T MRI predicts amelioration of neurodegeneration in the brain after AAV gene therapy","volume":"17","author":"Gray-Edwards","year":"2020","journal-title":"Mol. Ther. Meth. Clin. Dev."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0210","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1620\/tjem.118.323","article-title":"Prenatal diagnosis and fetal pathology of tay-sachs disease","volume":"118","author":"Higami","year":"1976","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0215","first-page":"102","article-title":"Ultrastructural studies of eight cases of fetal Tay-Sachs disease","volume":"30","author":"Adachi","year":"1974","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0220","doi-asserted-by":"crossref","first-page":"302","DOI":"10.5414\/NPP27302","article-title":"Neuropathology of chronic GM2 gangliosidosis due to hexosaminidase A deficiency","volume":"27","author":"Kornfeld","year":"2008","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0225","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/jnnp.59.5.520","article-title":"Early and severe sensory loss in three adult siblings with hexosaminidase A and B deficiency (Sandhoff disease)","volume":"59","author":"Schnorf","year":"1995","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2021.08.009_bb0230","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00688589","article-title":"Spinal ganglia and peripheral nerves from a patent with Tay-Sachs disease. Morphological and ganglioside studies","volume":"66","author":"Abe","year":"1985","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0235","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1111\/j.1471-4159.2010.06733.x","article-title":"Restricted ketogenic diet enhances the therapeutic action of N-butyldeoxynojirimycin towards brain GM2 accumulation in adult Sandhoff disease mice","volume":"113","author":"Denny","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0240","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0022-2275(20)39446-3","article-title":"Generalized accumulation of neutral glycosphingolipids with G M2 ganglioside accumulation in the brain","volume":"13","author":"Snyder","year":"1972","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0245","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1471-4159.1987.tb00969.x","article-title":"Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease?","volume":"49","author":"Rosengren","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2021.08.009_bb0250","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/neup.12088","article-title":"Late onset GM2 gangliosidosis presenting with motor neuron disease: an autopsy case","volume":"34","author":"Yokoyama","year":"2014","journal-title":"Neuropathology"},{"key":"10.1016\/j.ymgme.2021.08.009_bb0255","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1021\/ac702350g","article-title":"Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs\/Sandhoff disease","volume":"80","author":"Chen","year":"2008","journal-title":"Anal. Chem."},{"issue":"10","key":"10.1016\/j.ymgme.2021.08.009_bb0265","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1093\/brain\/awq257","article-title":"Magnetic resonance imaging pattern recognition in hypomyelinating disorders","volume":"133","author":"Steenweg","year":"2010","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.ymgme.2021.08.009_bb0270","first-page":"0","article-title":"Tay-Sachs disease in Jacob sheep","volume":"101","author":"Torres","year":"2010"},{"key":"10.1016\/j.ymgme.2021.08.009_bb6271","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2021.05.001","article-title":"A pathogenic HEXA missense variant in wild boars with Tay-Sachs diseas","author":"Bertani","year":"2021","journal-title":"Mol Genet Metab"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:51:30Z","timestamp":1761090690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719221007733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":51,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1096719221007733"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.08.009","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural history of Tay-Sachs disease in sheep","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}